Temozolomide D3
| Product Name | Temozolomide D3 |
|---|---|
| Alternate Names | Temozolomide Stable Isotopes, Stable Isotopes of Temozolomide |
| CAT No. | CS-O-06994 |
| CAS No. | 208107-14-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 197.2 g/mol |
| Mol. For. | C6H3D3N6O2 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Temozolomide |
| Purity | Not less than 95 % |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | NC(C1=C(N=NN(C([2H])([2H])[2H])C2=O)N2C=N1)=O |
| Canonical Smiles | CN1C(=O)N2C=NC(=C2N=N1)C(=O)N |
| InchIKey | BPEGJWRSRHCHSN-FIBGUPNXSA-N |
| Inchl | InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)/i1D3 |
| IUPAC | 4-oxo-3-(trideuteriomethyl)imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Temozolomide D3 is a deuterated form of the chemotherapy drug Temozolomide. It is used in the treatment of certain types of brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Temozolomide D3 works by inhibiting the growth of cancer cells.
Temozolomide D3 is a prodrug which means it is inactive until it is metabolized by the body. Once inside the body, it is converted into its active form, which is responsible for its anti-cancer effects. It works by damaging the DNA of cancer cells, which in turn leads to their death.
The chemical formula of Temozolomide D3 is C9H6D3N5O2. It has a molecular weight of 216.22 g/mol. It is a white to light yellow crystalline powder that is soluble in water. The deuterated form of Temozolomide is used in clinical studies to determine the pharmacokinetic properties of the drug.
Temozolomide D3 is administered orally in the form of capsules. The recommended dose of the drug is determined by the patient's body weight and the type of cancer being treated. The drug is generally well tolerated, but like all chemotherapy drugs, it may cause side effects such as fatigue, nausea, vomiting, and low blood cell counts.
In conclusion, Temozolomide D3 is a deuterated form of the chemotherapy drug Temozolomide which is used in the treatment of certain types of brain tumors. It works by inhibiting the growth of cancer cells and damaging their DNA. The drug is administered orally in the form of capsules and may cause side effects such as fatigue, nausea, vomiting, and low blood cell counts.
Get an Instant Quote
Related Compounds
Temozolomide Metabolite-MTIC D3 |